Home > Insider Trading > Filing (0001022079-20-000002)

Filing Details

Accession Number:: 0001022079-20-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-03 16:39:20
Reporting Period:: 2020-01-02

Accepted Time:: 2020-01-03 16:39:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1022079	Quest Diagnostics Inc	DGX	Services-Medical Laboratories (8071)	161387862

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1599837	E. J. Davis	500 Plaza Drive Secaucus NJ 07094	Evp, General Diagnostics	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-01-02	65,681	$71.17	102,215	No	4	M	Direct
Common Stock	Acquisiton	2020-01-02	77,865	$66.51	180,080	No	4	M	Direct
Common Stock	Disposition	2020-01-02	58,258	$105.46	121,822	No	4	S	Direct
Common Stock	Disposition	2020-01-02	7,423	$106.51	114,399	No	4	S	Direct
Common Stock	Disposition	2020-01-02	69,003	$105.45	45,396	No	4	S	Direct
Common Stock	Disposition	2020-01-02	8,853	$106.51	36,543	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualifed Stock Option (right to buy)	Disposition	2020-01-02	65,681	$71.17	65,681	$71.17
Common Stock	Non-Qualifed Stock Option (right to buy)	Disposition	2020-01-02	77,865	$66.51	77,865	$66.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-02-23	No	4	M	Direct
0		2026-02-25	No	4	M	Direct

Footnotes

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019.
This transaction was executed in multiple trades at prices ranging from $105.00 to $105.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $106.00 to $106.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $105.00 to $106.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $106.01 to $106.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested in three equal annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018.
The options vested in three equal annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019.